This workgroup will focus on mechanisms (pharmacological, molecular, etc.) of behavior related to neuropsychiatric conditions (broadly defined). The group will rely heavily in the beginning on basic science projects, but translational and clinical researchers are encouraged to participate, as these scientists will bring complementary expertise. All areas (discovery-based omics, molecular, cellular, and behavior) are encouraged to participate.
Key Persons: Tom Green, UTMB and Francesco Versace, MD Anderson